Evidence map›Paper›PMID 41550156›Full record

ArticlePharmaceutical science advances2024

Delayed treatment with hydro-ethanolic extract of

Arnaud Fondjo Kouam, Ibrahim Njingou, Nina Jeannette Pekam Magoudjou, Hamed Bechir Ngoumbe, Philipe Herman Nfombouot Njitoyap, Elisabeth Menkem Zeuko'o, Frédéric Nico Njayou, Paul Fewou Moundipa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutical science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Arnaud Fondjo KouamMedical Research and Applied Biochemistry Laboratory, Department of Biomedical Sciences, Faculty of Health Sciences, University of Buea, PO Box 63, Buea, Cameroon.
Ibrahim NjingouLaboratory of Pharmacology and Toxicology, Department of Biochemistry, POBox 812, Faculty of Science, University of Yaoundé 1, Cameroon.
Nina Jeannette Pekam MagoudjouLaboratory of Pharmacology and Toxicology, Department of Biochemistry, POBox 812, Faculty of Science, University of Yaoundé 1, Cameroon.
Hamed Bechir NgoumbeLaboratory of Pharmacology and Toxicology, Department of Biochemistry, POBox 812, Faculty of Science, University of Yaoundé 1, Cameroon.
Philipe Herman Nfombouot NjitoyapLaboratory of Pharmacology and Toxicology, Department of Biochemistry, POBox 812, Faculty of Science, University of Yaoundé 1, Cameroon.
Elisabeth Menkem Zeuko'oMedical Research and Applied Biochemistry Laboratory, Department of Biomedical Sciences, Faculty of Health Sciences, University of Buea, PO Box 63, Buea, Cameroon.
Frédéric Nico NjayouLaboratory of Pharmacology and Toxicology, Department of Biochemistry, POBox 812, Faculty of Science, University of Yaoundé 1, Cameroon.
Paul Fewou MoundipaLaboratory of Pharmacology and Toxicology, Department of Biochemistry, POBox 812, Faculty of Science, University of Yaoundé 1, Cameroon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of N-acetylcysteine against acetaminophen(APAP)-induced hepatotoxicity, a leading cause of liver injury, has several drawbacks, including short therapeutic windows.

Indexed as

Acetaminophen-hepatotoxicityHydro-ethanolic extractInhibition JNK phosphorylationK. grandifoliolaMitochondrial dysfunction

Identifiers

PMID41550156
PMCPMC12710059

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.